跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GIP non-peptide
首页
药物
GIP non-peptide
GIP non-peptide
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
DUAL-AGONIST COMPOUND FOR BOTH GLP-1 AND GIP RECEPTORS AND APPLICATION THEREOF
US 2023190879 A1
申请人: BEIJING TUO JIE BIOPHARMACEUTICAL CO LTD
优先权: 2020
CN
EP
US
WO
8 件公开
LONG-ACTING DUAL GIP/GLP-1 PEPTIDE CONJUGATES AND METHODS OF USE
EP 4352088 A4
申请人: SCRIPPS RESEARCH INST
优先权: 2021
CN
EP
US
WO
8 件公开
INCRETIN ANALOG-CONTAINING COMPOSITIONS AND USES THEREOF
EP 4312982 A1
申请人: LILLY CO ELI
优先权: 2021
CN
EP
US
WO
6 件公开
INCRETIN ANALOGS AND USES THEREOF
EP 4077365 A1
申请人: LILLY CO ELI
优先权: 2019
CN
EP
US
WO
5 件公开
INCRETIN ANALOG AND USE THEREOF
EP 4545086 A4
申请人: SHANGHAI MINWEI BIOTECHNOLOGY CO LTD
优先权: 2023
CN
EP
US
WO
4 件公开
RADIOLIGANDS FOR TARGETING CELL SURFACE RECEPTORS AND USES THEREOF
EP 4719498 A1
申请人: FULL LIFE TECH UK LIMITED
优先权: 2023
CN
EP
WO
3 件公开
MULTI-RECEPTOR AGONIST AND MEDICAL USE THEREOF
US 2022168396 A1
申请人: JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD
优先权: 2019
EP
US
3 件公开
Novel analogues of glucose-dependent insulinotropic polypeptide
US 2005137135 A1
申请人: HINKE SIMON A
优先权: 2003
US
2 件公开
MICRORNA AS A BIOMARKER OF PANCREATIC ISLET BETA-CELL ENGAGEMENT
US 2012034608 A1
申请人: ZHOU YUN-PING
优先权: 2010
US
Medicine capable of promoting secretion of glp-1 and restraining secretion of gip
CN 102961388 A
申请人: SANWA CORNSTARCH CO LTD
优先权: 2011
CN
第 1 / 2 页
上一页
下一页
药物
反馈